Analysts expect that Sorrento Therapeutics, Inc. (NASDAQ:SRNE – Get Rating) will announce ($0.25) earnings per share (EPS) for the current quarter, according to Zacks. Two analysts have provided estimates for Sorrento Therapeutics’ earnings, with the highest EPS estimate coming in at ($0.22) and the lowest estimate coming in at ($0.28). Sorrento Therapeutics posted earnings per […]
Related Keywords
, Sorrento Therapeutics Inc , Geode Capital Management , Jpmorgan Chase Co , Zacks Investment Research , Norges Bank , Blackrock Inc , Nasdaq , Sorrento Therapeutics , Get Rating , Sorrento Therapeutic , Investment Research , Street Corp , Capital Management , Nasdaq Srne , Srne , Medical , Ratings , Consensus ,
comparemela.com © 2020. All Rights Reserved.